Bioequivalence Study of Rivaroxaban

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The objectives of this study are to establish the bioequivalence between rivaroxaban tablet 15 mg and rivaroxaban granule formulation 15 mg, and to assess the safety and tolerability of rivaroxaban 15 mg in healthy adult male subjects.
Epistemonikos ID: c77f58e678c787f8b837c3137ad574222f983a4f
First added on: May 12, 2024